这篇文章不错，转发给_老虎社区_美港股上老虎

这篇文章不错，转发给大家看看

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":348293537308864,"tweetId":"348293537308864","gmtCreate":1726038634735,"gmtModify":1726038636528,"author":{"id":3575555959669966,"idStr":"3575555959669966","authorId":3575555959669966,"authorIdStr":"3575555959669966","name":"fafav","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>这篇文章不错，转发给大家看看</p></body></html>","htmlText":"<html><head></head><body><p>这篇文章不错，转发给大家看看</p></body></html>","text":"这篇文章不错，转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/348293537308864","repostId":2466264427,"repostType":2,"repost":{"id":"2466264427","kind":"news","pubTimestamp":1726035660,"share":"https://www.laohu8.com/m/news/2466264427?lang=&edition=full","pubTime":"2024-09-11 14:21","market":"fut","language":"zh","title":"康方生物(09926.HK)升逾4%  获摩通上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2466264427","media":"阿斯达克财经","summary":"摩通今日发表报告，考虑到AK112销售预测上调，该行相应将康方生物销售额预测调升逾40%，继续预期该公司可于2026年达至收支平衡，目标价由原先59元上调15%至68元，重申康方生物为中国生物科技领域中的首选，评级“增持”。康方生物昨日北水南向净流入2,774万元，股价曾高见59.9元，受制5月31日60元高位回落。药明生物昨日于联交所回购1,100万股，现报11.2元，回升2.75%，成交4,155.67万股，涉资4.62亿元。","content":"<html><body><div> <span> <p>摩通今日发表报告，考虑到AK112销售预测上调，该行相应将<a href=\"https://laohu8.com/S/09926\">康方生物</a>(09926.HK)<span> </span>销售额预测调升逾40%，继续预期该公司可于2026年达至收支平衡，目标价由原先59元上调15%至68元，重申康方生物为中国生物科技领域中的首选，评级“增持”。<br/>康方生物昨日(10日)北水南向净流入2,774万元，股价曾高见59.9元，受制5月31日60元高位回落。今日再上试60元阻力，最高见59.75元。现报58元，升4.13%，成交1,202.81万股，涉资7.06亿元。<br/><span></span><br/><a href=\"https://laohu8.com/S/02269\">药明生物</a>(02269.HK)<span> </span>昨日于联交所回购1,100万股，现报11.2元，回升2.75%，成交4,155.67万股，涉资4.62亿元。<a href=\"https://laohu8.com/S/603259\">药明康德</a>(02359.HK)<span> </span>董事会批准2024年第三次回购A股方案，资金总额10亿人民币，今日股价最高见33.9元，现报33.85元，升5.12%，成交652.51万股，涉资2.18亿元。<a href=\"https://laohu8.com/S/02268\">药明合联</a>(02268.HK)<span> </span>今日高开0.32%，最高见19.42元。现报19.2元，升2.67%，成交308.15万股，涉资5,869.8万元。(ad/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-09-11 12:25。)</p><div></div>AASTOCKS新闻 </span> </div></body></html>","source":"aastocks_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康方生物(09926.HK)升逾4%  获摩通上调目标价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康方生物(09926.HK)升逾4%  获摩通上调目标价\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-11 14:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1380631/latest-news/AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>摩通今日发表报告，考虑到AK112销售预测上调，该行相应将康方生物(09926.HK) 销售额预测调升逾40%，继续预期该公司可于2026年达至收支平衡，目标价由原先59元上调15%至68元，重申康方生物为中国生物科技领域中的首选，评级“增持”。康方生物昨日(10日)北水南向净流入2,774万元，股价曾高见59.9元，受制5月31日60元高位回落。今日再上试60元阻力，最高见59.75元。现报58...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1380631/latest-news/AAFN\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","relate_stocks":{"09926":"康方生物"},"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1380631/latest-news/AAFN","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2466264427","content_text":"摩通今日发表报告，考虑到AK112销售预测上调，该行相应将康方生物(09926.HK) 销售额预测调升逾40%，继续预期该公司可于2026年达至收支平衡，目标价由原先59元上调15%至68元，重申康方生物为中国生物科技领域中的首选，评级“增持”。康方生物昨日(10日)北水南向净流入2,774万元，股价曾高见59.9元，受制5月31日60元高位回落。今日再上试60元阻力，最高见59.75元。现报58元，升4.13%，成交1,202.81万股，涉资7.06亿元。药明生物(02269.HK) 昨日于联交所回购1,100万股，现报11.2元，回升2.75%，成交4,155.67万股，涉资4.62亿元。药明康德(02359.HK) 董事会批准2024年第三次回购A股方案，资金总额10亿人民币，今日股价最高见33.9元，现报33.85元，升5.12%，成交652.51万股，涉资2.18亿元。药明合联(02268.HK) 今日高开0.32%，最高见19.42元。现报19.2元，升2.67%，成交308.15万股，涉资5,869.8万元。(ad/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-09-11 12:25。)AASTOCKS新闻","news_type":1},"isVote":1,"tweetType":1,"viewCount":414,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/348293537308864"}